IRCT20150529022468N5CompletedPhase 2
Comparison of efficacy and safety of intra lesional tranexamic acid injection versus topical Kligman’s formula application in the treatment of macular amyloidosis
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •Age range 18 to 50 years
- •Suffering from macular amyloidosis
Exclusion Criteria
- •Pregnant or lactating women
- •History of cardiovascular disease
- •Keloid patients
- •Patients taking anticoagulants
- •Any allergy to the study drugs
- •History of bleeding disorder
- •Topical treatment three months before entering the study
- •No consent to participate in the study
Investigators
Similar Trials
Completed
Phase 4
A clinical trial to study the effects of drug named Triamcinolone alone or combination of Triamcinolone and 5- Fluorouracil in patients with Keloid or hypertrophic scarsACTRN12612000546853Farrukh Aslam Khalid120
Not yet recruiting
Phase 3
Effect of different strength of intralesional triamcinolone acetonide in alopecia areata.CTRI/2024/02/063138Institute of Medical Sciences BH
Completed
Unknown
comparison of the effectiveness of placentrex, hyaluronidase, and dexamethasone in the treatment of Oral submucous fibrosis.CTRI/2024/01/061403Jay Goyal160
Recruiting
Not Applicable
Treatment of common wartsCTRI/2017/07/009028il50
Completed
Not Applicable
To compare efficacy of treatment by intralesional bleomycin and intralesional vitamin D-3 in common warts.CTRI/2021/04/032610Department of Dermatology Venereology and Leprosy32
